Aaron Aday, MD, MSc, FAHA, FSVM, is a cardiologist and vascular medicine specialist in the Division of Cardiovascular Medicine at Vanderbilt University Medical Center. He is co-director of the Vascular Medicine Section.
Dr. Aday's research training background is in cardiovascular epidemiology and clinical trials with a focus on peripheral vascular diseases. His research program has several key focus areas:
- Conducting mechanistic clinical trials to understand how peripheral artery disease develops and how these mechanisms impact clinical outcomes.
- Using large epidemiological cohorts to understand the development of vascular disorders, including peripheral artery disease, aortic aneurysm, and venous thromboembolism.
- Collecting biospecimens, phenotypic data, and biophysical measures to understand how lipedema develops and impacts the lives of patients.
His research program is an enrolling site in the the North American Registry for Fibromuscular Dysplasia, and our group participates in industry-sponsored clinical trials of new therapies for atherosclerosis and vascular disease.
Dr. Aday's clinical interests are venous disease, such as deep vein thrombosis, pulmonary embolism, and varicose veins. In addition, he specializes in the care of patients with aortic disease, peripheral artery disease, and other rare forms of vascular disease.
Dr. Aday's research interests focus on the identification of novel risk factors in the development of peripheral artery disease, venous thromboembolism, and other forms of vascular disease. He and his colleagues study these risk factors by using physiologic studies, epidemiologic cohorts, and clinical trials.
» Email Aaron Aday
Key Research Areas
Cardiovascular Imaging
Vascular
Grants
2023-2025: Lipedema Foundation, Building Lipedema Research Resources
2021-2026: NIH K23, The Impact of Thrombosis and Antithrombotic Therapy on Peripheral Artery Disease
Honors and Awards
2023-2025: Lipedema Foundation, Building Lipedema Research Resources
2021-2026: NIH K23, The Impact of Thrombosis and Antithrombotic Therapy on Peripheral Artery Disease